Smoking, obesity, and disability worsening in PPMS: an analysis of the INFORMS original trial dataset

Background Smoking and obesity are recognized modifiable risk factors associated with a higher MS incidence, but their impact on physical and cognitive disability worsening is less clear. Objective To investigate the impact of smoking and obesity on disability worsening in primary progressive MS (PPMS). Methods We used data from INFORMS (clinicaltrials.gov identifier: NCT00731692), a large randomized-controlled trial in PPMS to compare significant worsening on the EDSS, T25FW, NHPT, and PASAT between smokers and non-smokers, and between BMI groups, at 12, 24, and 33 months of follow-up. We investigated the association of smoking and BMI at screening and the risk of disability worsening with logistic regression models. Results Smokers had significantly higher EDSS scores throughout the trial. EDSS was not significantly different between BMI categories. No other outcome measure was significantly different between smokers and non-smokers and between BMI categories throughout the trial. Neither smoking status nor BMI were associated with significant worsening on any outcome measure at any time point during follow-up. Conclusion Despite the known effects on MS incidence, smoking and BMI were not associated with the risk of physical and cognitive disability worsening over 3 years in this well-characterized PPMS trial cohort.

Automated summary

In primary progressive MS (PPMS) patients, smoking was found to be associated with disability worsening, while obesity showed no significant correlation. Over three years of follow-up, smoking and BMI were not linked to physical and cognitive disability worsening risk.